Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ALNY will decline by -2.94% over the next 2 Weeks and hit $447.12 by Wednesday, October 15, 2025. In that time frame, ALNY's share price is expected to range between $437.63 and $456.76.
BearishAverageBullishALNY shares rose +0.07% in Thursday, October 2, 2025's trading session, rising from a previous close of $460.65 to move at $460.99. The stock demonstrated notable intraday movement (see ALNY's key stats for a full breakdown), fluctuating between $446.18 and $461.53, a +3.44% trading range. While recent weeks have seen some volatility, ALNY has managed to secure a +1.64% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.27M shares changing hands, 102.2K fewer than the previous session. This amounted to $584.44M in total market activity.
Will ALNY Continue Its Downward Trend?
According to analyst ratings and projections for ALNY, Alnylam Pharmaceuticals, Inc. shares are anticipated to decrease by -0.93%, potentially reaching $456.76 per share by October 15, 2025. Short-term technical indicators currently suggest a neutral sentiment for ALNY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the ALNY stock forecast, now is not the best time to buy ALNY stock because its current trading price is +3.10% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ALNY covering social and institutional perspectives.
ALNY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ALNY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.29% to 60.62%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 63.42%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 61.48%, points to growing bullish momentum over the long term. Insights into ALNY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Alnylam Pharmaceuticals Short-Term Forecasts
ALNY Forecast For Next 5 Days
Our algorithm anticipates Alnylam Pharmaceuticals (ALNY) stock could hit $489.69 by Oct 09, 2025. This represents a +6.23% rise from today's price, following a +0.50% change over the past five days.
ALNY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Alnylam Pharmaceuticals, Inc. (ALNY) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $476.60, which would mean a +3.39% increase from the current price of $460.99. Projections for this period range from a high of $534.75 to a low of $430.88.
ALNY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Alnylam Pharmaceuticals's price over the next three months point to a drop. ALNY stock is expected to peak at $497.54 on Jan 01, 2026 after potentially dipping to $417.09 on Oct 13, 2025. On average, ALNY is likely to trade around $458.74 in the coming 90 days.
Alnylam Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Alnylam Pharmaceuticals (ALNY) is expected to trade between $417.09 and $496.02 throughout 2025. This would result in an average price of $458.20, potentially offering investors a -0.61% return from current levels.
Alnylam Pharmaceuticals, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, Alnylam Pharmaceuticals, Inc. (ALNY) is positioned to show a strong performance in October 2025. The price is predicted to move between $417.09 and $477.06, settling at an average of $448.64. This could translate to a -2.68% loss.
November 2025
Based on current market signals, Alnylam Pharmaceuticals, Inc. is projected to trend november 2025. We forecast a trading range from $429.10 to $493.35, with a likely average price of $460.51. Investors could expect a potential return of -0.10%.
December 2025
Our predictive algorithms indicate Alnylam Pharmaceuticals, Inc. stock may see a shift in December 2025. The expected range spans $438.70–$496.02, with an average target of $465.32. This represents a positive outlook and a possible gain of +0.94%.
January 2026
Analyzing established trends, Alnylam Pharmaceuticals, Inc. looks set to move in January 2026. Projections place the stock between $444.02 and $509.29, averaging around $478.08. This suggests a +3.71% gain from current levels.
February 2026
Market indicators suggest Alnylam Pharmaceuticals, Inc. could experience notable changes during February 2026. Prices could fluctuate within $452.81 to $511.83, with a midpoint forecast of $481.30. The stock might deliver a +4.41% gain.
March 2026
Forecasting for March 2026, models estimate that Alnylam Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $439.97 and $494.35, averaging $467.62. This signals a positive trajectory with potential returns around +1.44%.
April 2026
According to our latest forecast models, Alnylam Pharmaceuticals, Inc. (ALNY) is positioned to show a strong performance in April 2026. The price is predicted to move between $445.57 and $509.41, settling at an average of $478.84. This could translate to a +3.87% gain.
May 2026
Based on current market signals, Alnylam Pharmaceuticals, Inc. is projected to trend may 2026. We forecast a trading range from $458.68 to $512.81, with a likely average price of $484.20. Investors could expect a potential return of +5.03%.
June 2026
Our predictive algorithms indicate Alnylam Pharmaceuticals, Inc. stock may see a shift in June 2026. The expected range spans $466.63–$532.28, with an average target of $497.30. This represents a positive outlook and a possible gain of +7.88%.
July 2026
Analyzing established trends, Alnylam Pharmaceuticals, Inc. looks set to move in July 2026. Projections place the stock between $466.08 and $530.56, averaging around $498.79. This suggests a +8.20% gain from current levels.
August 2026
Market indicators suggest Alnylam Pharmaceuticals, Inc. could experience notable changes during August 2026. Prices could fluctuate within $458.11 to $513.15, with a midpoint forecast of $486.70. The stock might deliver a +5.58% gain.
September 2026
Forecasting for September 2026, models estimate that Alnylam Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $463.53 and $530.52, averaging $499.06. This signals a positive trajectory with potential returns around +8.26%.
October 2026
According to our latest forecast models, Alnylam Pharmaceuticals, Inc. (ALNY) is positioned to show a strong performance in October 2026. The price is predicted to move between $483.14 and $522.04, settling at an average of $504.16. This could translate to a +9.36% gain.
ALNY's history of dividends and stock splits also plays a role in long-term investor confidence.